Biliary Tract Adenocarcinoma — Trials

Biliary Tract Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 4
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Academic and Community Cancer Research United
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05350943	HAIC Combined With Toripalimab and Donafenib for Advanced BTC	unknown	Phase 2	70	Lu Wang, MD, PhDOTHER	1	Oct 18, 2022	clinicaltrials
NCT04156958	Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma(FSTAMBTA)	unknown	Phase 2	33	Sichuan UniversityOTHER	1	Nov 8, 2019	clinicaltrials